Research Raises Eyebrow over Breast Cancer Screening in Older Women

Pharmaceutical

The latest research highlights additional concerns about the effectiveness of screening for breast cancer, showing that those aged 70 and up who received mammograms were more likely to be identified with tumors that caused no harm to their safety than those who did not choose to participate in testing.

The U.S. Preventive Services Task Force, a research council that develops clinical preventative action recommendations, has suggested that females aged 50 to 74 receive tests every two years. However, it has stated that there is insufficient data to determine the risks and advantages of mammography for women aged 75 and above. The task team is currently evaluating a draft suggestion to reduce the age for routine mammograms to 40.

“Concerns rise due to over diagnosis of breast cancer in older women.“

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

See all the latest jobs in Pharmaceutical
Return to news